Clinical Trials Logo

Clinical Trial Summary

This study will evaluate the anti-cancer effects of crizotinib when compared with standard chemotherapy in patients with ALK positive lung cancer.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01154140
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 3
Start date January 13, 2011
Completion date November 30, 2016